PROALT  

Diagnostics & therapeutics in colorectal cancer

OWNER

(See Profile)


Sector

Diagnostics
Immunology

Stage

PoC
Pre-clinical

Funding needed

350 000€

Country

Spain

Potential peak sales of ~226 M€ for a 8% market share

Non invasive and low cost

Expected sensitivity and specificity 85%-90%, above commonly used diagnostic tests

Therapeutic pathway different from commercial antibodies currently in the market

Potential peak sales of ~2,139 M€ for a 40% market share in main markets

Major players in monoclonal antibodies’ market for colorectal cancer treatment, had sales of $9,063 M in 2013

If you want to have more information or you want to review the project, you have to login or register
Contact the entrepreneur
Share your thoughts with other BioExperts

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar